BRAF and melanoma: In order to confirm these in silico findings we performed qRT-PCR of BRAF mutated, treatment sensitive melanoma cell lines (A375, WM9, WM35 and WM902B) and found that miR-129-5p expression was increased after Vemurafenib treatment.